DAFTAR PUSTAKA

1. LaBrecque DR. Mass lesion and neoplasia of the liver. In: Glendell JH, McQuaid KR, Friedman SL, editors. Current gastroenterology. Connecticut : Appleton and Lange; 1996. p. 598-626.
2. Yuen MF, Lai CL. Screening for hepatocellular carcinoma: survival benefits and cost-effectiveness. Annals of oncology 2003.14: 1463-67.
3. Dienstag JL, Isselbacher KJ. Tumors of the liver and biliary tract. In : Braunwald, Fauci, Kasper, Hauser, Longo, Jameson, editors. Harrison's principles of internal medicine. 15th ed. Singapore : McGraw-Hill; 2003. p. 588-91.
4. Doherty GM, Way LW. Liver and portal venous system . In : Doherty GM, Way LW. Current surgical diagnosis and treatment. 11th ed. Singapore: McGraw-Hill; 2003. p. 565-94.
5. Aminudin R. Karsinoma hati. In : Noer MS, editor. Buku ajar ilmu penyakit dalam. 3rd ed. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2003. p. 310-16
6. Iida H, Honda M, Kawai HF, Yamashita T, Shirota Y, Wang BC, Miao H, Kaneko S. Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma. Gut 2005; 54(6): 843-51
7. Zheng M, Ruan Y, Yang M, Guan Y, Wu Z. The comparative study on ultrastructure and immunohistochemistry in AFP negative and positive hepatocellular carcinoma. J Huazhong Univ Sci Technolog Med Sci 2004;24 (6): 547-9, 559
8. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53, and beta-catenin mutations. Int J Cancer 2004; 112(1): 44-50
9. Sidharta. Atlas ultrasonografi abdomen dan beberapa organ penting. 2nd ed. Jakarta: Balai Penerbit Fakultas Kedokteran Universitas Indonesia; 2000
10. Taketa K, Okada S, Win N, Hlaing NK, Wind KM. Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar. Acta Med Okayama 2002 ;56(6):317-20
11. Yuen MF, Lai CL. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 2005; 19(1):91-9
12. Yang SZ, Dong JH, Li K, Zhang Y, Zhu J. Detection of AFPmRNA and melanoma antigen gene-1 mRNA as markers of disseminated hepatocellular carcinoma cells in blood. Hepatobiliary Pancreat Dis Int 2005; 4(2):227-33
13. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C, and non-B non-C patients. Hepatogastroenterology 2003;50(54):2022-7
14. Tangkijvanich P, Suwangool P, Mahachai V. Comparison of clinical features and survival of patients with hepatitis B- and hepatitis C- associated hepatocellular carcinoma in Thailand. J Med Assoc Thai 2003; 86 Suppl 2:S250-6
15. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin. Hepatogastroenterology 2003;50(54):2072-8
16. Rapaccini GL, Pompili M, Caturelli E, Covino M, Lippi ME, Beccaria S, Cedrone A, Riccardi L, Siena DA, Gasbarrini G. Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 conscutive patients. Liver Int 2004; 24(2):124-30

<<Previous Page

Berdiri tahun 2005, dipublikasi oleh: Tim Karya Tulis Ilmiah Mahasiswa Fakultas Kedokteran Universitas Diponegoro Semarang